Quanterix secures $15 million in series A financing
Arch Venture Partners, Bain Capital Ventures, and Flagship Ventures co-led the round. Proceeds from the financing will be used to validate the platform and accelerate development of ultrasensitive
The US Food and Drug Administration (FDA) has approved Pfizer’s Tukysa (tucatinib) along with pertuzumab and trastuzumab as a maintenance therapy for breast cancer.